The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Harvard Medical School designates this live activity for a maximum of 38.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity. This activity meets the criteria of Massachusetts Board of Registration in Medicine for 11.5 hours of Risk Management Study. This includes 4 Credits of Opioid Education and Pain Management training and 2.5 Credits of End-of-Life Care Studies. Please check your individual state licensing board requirements before claiming these credits.
This Live activity, Office Practice of Primary Care Medicine, with a beginning date of 03/17/2014, has been reviewed and is acceptable for up to 38.50 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
This course is designed to meet the following Accreditation Council of Graduate Medical Education competencies:
- Patient care
- Medical knowledge
- Practice-based learning and improvement
- System-based practice
- Interpersonal and communication skills
Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g., planners, faculty, reviewers, and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.